Fig. 3From: FLT3 inhibitors in acute myeloid leukaemia: assessment of clinical effectiveness, adverse events and future research—a systematic review and meta-analysisForest plot of estimated event-free survival (calculated and reported data, uncensored population), grouped by FLT3 inhibitorBack to article page